1. Home
  2. BFC vs NRIX Comparison

BFC vs NRIX Comparison

Compare BFC & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$146.44

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$19.30

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
NRIX
Founded
1894
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
BFC
NRIX
Price
$146.44
$19.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$157.00
$30.50
AVG Volume (30 Days)
78.0K
2.7M
Earning Date
04-16-2026
04-08-2026
Dividend Yield
1.52%
N/A
EPS Growth
11.23
N/A
EPS
1.78
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$58.67
N/A
Revenue Next Year
$2.01
$48.05
P/E Ratio
$81.27
N/A
Revenue Growth
N/A
99.31
52 Week Low
$112.18
$8.20
52 Week High
$153.00
$22.50

Technical Indicators

Market Signals
Indicator
BFC
NRIX
Relative Strength Index (RSI) 57.32 71.08
Support Level $140.47 $14.86
Resistance Level $147.53 $19.71
Average True Range (ATR) 3.67 1.35
MACD 0.32 0.34
Stochastic Oscillator 83.44 90.78

Price Performance

Historical Comparison
BFC
NRIX

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: